Aktuellt
SENASTE
Redeye retains its positive view of Proact despite somewhat reducing our Base Case and 2023-2024 EBITA forecasts. Sales was solid in the quarter, with the highlight being 8% organic growth in recurring revenue. However, cost inflation hurt margins, which Proact has not yet fully compensated for, mostly due to its three years Cloud and Support contracts.
LÄS MER
